Skip to main content
Equibles

UBS Group AG

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,536,627
-$2,613,782 QoQ
Shares Held
1,939,654
-14.2% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 209 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. SPRY ranks #92 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in SPRY

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,536,627 1,939,654
2026-03-31 $18,150,409 2,260,325
2025-12-31 $25,756,586 2,210,866
2025-09-30 $6,631,853 659,886
2025-06-30 $15,128,014 866,935
2025-03-31 $7,437,068 591,182
2024-12-31 $10,683,995 1,012,701
2024-09-30 $1,593,288 109,882
2024-06-30 $552,486 64,922
2024-03-31 $1,067,386 104,441
2023-12-31 $9,469 1,728
2023-03-31 $18,898 2,903
2022-09-30 $63 12
2022-06-30 $2,128 502
2022-03-31 $1,799 513
2021-12-31 $525,074 78,840
2021-09-30 $137,025 13,730
2021-06-30 $5,405 175
2021-03-31 $154,406 3,539
2020-12-31 $4,309 93